lysergic acid diethylamide has been researched along with Blood Protein Disorders in 1 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Blood Protein Disorders: Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, L | 1 |
1 review available for lysergic acid diethylamide and Blood Protein Disorders
| Article | Year |
|---|---|
A biochemical survey of schizophrenia.
Topics: Amines; Amphetamine; Antibodies; Antigen-Antibody Reactions; Antimetabolites; Biotransformation; Blo | 1970 |